Literature DB >> 2884570

An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2.

A G DiLella, J Marvit, K Brayton, S L Woo.   

Abstract

Phenylketonuria (PKU) is an autosomal recessive human genetic disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH, phenylalanine 4-monooxygenase, EC 1.14.16.1). PKU is a common inborn error of amino-acid metabolism in caucasian populations and approximately 1 in 50 individuals are carriers of a PKU allele. To define the molecular basis of PKU, we characterized twelve restriction fragment-length polymorphism (RFLP) haplotypes of the PAH locus in the northern European population and observed that 90% of the PKU alleles in this population are confined to four common RFLP haplotypes. We have recently reported a splicing mutation in the PAH gene that is associated with RFLP haplotype 3 which is present at about 40% of mutant alleles. We now report the molecular lesion associated with the RFLP haplotype 2 mutant allele. This defect is caused by a C-to-T transition in exon 12 resulting in an amino-acid substitution (Arg to Trp) at residue 408 of PAH. Direct hybridization analysis of the point mutation using a specific oligonucleotide probe demonstrated that this mutation is also in linkage disequilibrium with RFLP haplotype 2 alleles that make up about 20% of mutant PAH genes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884570     DOI: 10.1038/327333a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  92 in total

1.  CpG hotspot causes second mutation in codon 408 of the phenylalanine hydroxylase gene.

Authors:  S J Ramus; S M Forrest; J A Saleeba; R G Cotton
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

2.  Linkage disequilibrium between phenylketonuria and RFLP haplotype 1 at the phenylalanine hydroxylase locus in Portugal.

Authors:  C Caillaud; L Vilarinho; A Vilarinho; F Rey; M Berthelon; R Santos; S Lyonnet; M L Briard; R V Osorio; J Rey
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

3.  Simple and rapid detection of phenylketonuria mutation tightly linked to haplotype 2 by modified polymerase chain reaction.

Authors:  Y Matsubara; K Narisawa; K Tada
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 4.  Heterogeneity of phenylketonuria at the clinical, protein and DNA levels.

Authors:  R G Cotton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.

Authors:  R Asakai; D W Chung; O D Ratnoff; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Molecular genetics of phenylketonuria in Orientals: linkage disequilibrium between a termination mutation and haplotype 4 of the phenylalanine hydroxylase gene.

Authors:  T Wang; Y Okano; R Eisensmith; S Z Huang; Y T Zeng; W H Lo; S L Woo
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

7.  Recurrent nonsense mutation in exon 7 of the phenylalanine hydroxylase gene.

Authors:  B Dworniczak; L Kalaydjieva; C Aulehla-Scholz; K Ullrich; I Kremensky; B Radeva; J Horst
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

8.  Molecular heterogeneity at the phenylalanine hydroxylase locus in the population of the south-west of England.

Authors:  L A Tyfield; M J Osborn; J B Holton
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

9.  Severity of mutation in the phenylalanine hydroxylase gene influences phenylalanine metabolism in phenylketonuria and hyperphenylalaninaemia heterozygotes.

Authors:  E Svensson; L Iselius; L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Haplotype distribution at the phenylalanine hydroxylase locus in PKU families from the Moravian area of Czechoslovakia.

Authors:  L Kozák; D Dvoráková; A Pijácková; J Kamarýt
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.